Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Journal De Chirurgie|December 1, 1982
[Digestive endometriosis. Current concepts]P Caligaris, M J Ducassou, R Masselot, et al.
Annales De Gastroenterologie Et D'Hepatologie|March 1, 1984
[Duodenal varices. Review of the literature apropos of a case]R Boutboul, Y P Le Treut, B Maurin, et al.
Annales De Gastroenterologie Et D'Hepatologie|December 1, 1984
[Left internal paraduodenal hernia: a case in a young adult]B Maillet, Y P Le Treut, R Boutboul, et al.
Pharmaceutical Research|September 1, 1996
Solubility behavior, phase transition, and structure-based nucleation inhibition of etanidazole in aqueous solutionsM B Maurin, S M Rowe, K S Field, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 12, 2010
Thermal decomposition of matrix metalloproteinase inhibitors: evidence of solid state dimerizationShelley R Rabel Riley, Rodney D Vickery, Gregory A Nemeth, et al.
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|January 21, 2003
New applications of electron diffraction in the pharmaceutical industry: polymorph determination by using a combination of electron diffraction and synchrotron X-ray powder diffraction techniquesZ G Li, R L Harlow, C M Foris, et al.
Journal of Pharmaceutical Sciences|March 3, 1999
Polymorph determination for the GP IIb/IIIa antagonist, roxifiban, using a combination of electron diffraction and synchrotron X-ray powder diffraction techniquesZ G Li, R L Harlow, C M Foris, et al.
Journal of Pharmaceutical Sciences|November 16, 2002
Polymorphism of roxifibanMichael B Maurin, Rodney D Vickery, Shelley R Rabel, et al.
Journal of Pharmaceutical Sciences|September 12, 2000
Crystalline versus amorphous content of lumaxistrade mark analog XP280 using X-ray and electron diffraction methodsZ G Li, L Liang, R L Harlow, et al.
Chemistry & Biology|April 1, 1996
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450C N Hodge, P E Aldrich, L T Bacheler, et al.
Pageof 11